Delivery Order SPE2DB22D3301-SPE2DB24FZ2LF

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The order is for 4,565,350 units of the M-M-R II vaccine, a critical medical product used to prevent measles, mumps, and rubella. The fixed-price contract has a ceiling value of $14,081.38 and an ultimate completion date of August 6, 2024. This award is not associated with any set-aside program. Amerisourcebergen, as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract has a firm fixed-price of $1,537.14 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $73,001.76 firm fixed-price contract is for the supply of MMR-II (measles, mumps, and rubella) vaccines, with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The award has a ceiling value of $2,984.13 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The $22,723.12 firm-fixed-price contract has an ultimate completion date of August 29, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the efficient procurement of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The award has a firm fixed price of $3,156.27 and an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the government to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $86,445.85 and a completion date of September 3, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a $4,946.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen is a large supplier of prescription medications, over-the-counter drugs, and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. This delivery order...
This federal contract award is for the delivery of M-M-R II (Measles-Mumps-Rubella) vaccine vials to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,024.76 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025. This IDC...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of M-M-R II (measles, mumps, rubella) vaccine vials. The order has a ceiling value of $3,025.42 and a completion date of August 22, 2024. The contract is firm fixed price and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to support...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2LF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,565,386,390 doses of the M-M-R II (Measles, Mumps, and Rubella) vaccine, with a ceiling value of $11,272.36. It is a Firm Fixed Price contract with a period of performance through August 9, 2024.

Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of medications and medical supplies to military treatment facilities, veterans' hospitals, and other government healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued at up to $999,999,999 and $750,000, respectively, for delivering a comprehensive assortment of medical commodities. This particular award does not have a set-aside designation.

Generated 11/7/24, 9:42 AM